
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification
Bob Meeusen, Veerle Janssens
The International Journal of Biochemistry & Cell Biology (2017) Vol. 96, pp. 98-134
Closed Access | Times Cited: 91
Bob Meeusen, Veerle Janssens
The International Journal of Biochemistry & Cell Biology (2017) Vol. 96, pp. 98-134
Closed Access | Times Cited: 91
Showing 1-25 of 91 citing articles:
Targeting PP2A in cancer: Combination therapies
Sahar Mazhar, Sarah E. Taylor, Jaya Sangodkar, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2018) Vol. 1866, Iss. 1, pp. 51-63
Open Access | Times Cited: 121
Sahar Mazhar, Sarah E. Taylor, Jaya Sangodkar, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2018) Vol. 1866, Iss. 1, pp. 51-63
Open Access | Times Cited: 121
Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer
Otto Kauko, Jukka Westermarck
The International Journal of Biochemistry & Cell Biology (2018) Vol. 96, pp. 157-164
Closed Access | Times Cited: 102
Otto Kauko, Jukka Westermarck
The International Journal of Biochemistry & Cell Biology (2018) Vol. 96, pp. 157-164
Closed Access | Times Cited: 102
Druggable cancer phosphatases
Julia P. Vainonen, Majid Momeny, Jukka Westermarck
Science Translational Medicine (2021) Vol. 13, Iss. 588
Closed Access | Times Cited: 87
Julia P. Vainonen, Majid Momeny, Jukka Westermarck
Science Translational Medicine (2021) Vol. 13, Iss. 588
Closed Access | Times Cited: 87
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition
Yuanwang Pan, Han Han, Hai Hu, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 88-105.e8
Open Access | Times Cited: 48
Yuanwang Pan, Han Han, Hai Hu, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 88-105.e8
Open Access | Times Cited: 48
SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression
Liangzhi Wen, Kai Ding, Ze-Rui Wang, et al.
Cancer Research (2018) Vol. 78, Iss. 16, pp. 4680-4691
Closed Access | Times Cited: 75
Liangzhi Wen, Kai Ding, Ze-Rui Wang, et al.
Cancer Research (2018) Vol. 78, Iss. 16, pp. 4680-4691
Closed Access | Times Cited: 75
Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1
Otto Kauko, Susumu Y. Imanishi, Evgeny Kulesskiy, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 13, pp. 4194-4211
Open Access | Times Cited: 62
Otto Kauko, Susumu Y. Imanishi, Evgeny Kulesskiy, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 13, pp. 4194-4211
Open Access | Times Cited: 62
PP2A as a potential therapeutic target for breast cancer: Current insights and future perspectives
Yalong Qi, Lixi Li, Yuhan Wei, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116398-116398
Open Access | Times Cited: 7
Yalong Qi, Lixi Li, Yuhan Wei, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116398-116398
Open Access | Times Cited: 7
Targeted therapies don't work for a reason; the neglected tumor suppressor phosphatase PP 2A strikes back
Jukka Westermarck
FEBS Journal (2018) Vol. 285, Iss. 22, pp. 4139-4145
Open Access | Times Cited: 53
Jukka Westermarck
FEBS Journal (2018) Vol. 285, Iss. 22, pp. 4139-4145
Open Access | Times Cited: 53
Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late
Michiel Remmerie, Veerle Janssens
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2380-2380
Open Access | Times Cited: 51
Michiel Remmerie, Veerle Janssens
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2380-2380
Open Access | Times Cited: 51
PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
Michiel Remmerie, Veerle Janssens
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 48
Michiel Remmerie, Veerle Janssens
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 48
Long noncoding RNA GMAN promotes hepatocellular carcinoma progression by interacting with eIF4B
Jianbo Xu, Yijun Lu, Qiaoyu Liu, et al.
Cancer Letters (2019) Vol. 473, pp. 1-12
Closed Access | Times Cited: 45
Jianbo Xu, Yijun Lu, Qiaoyu Liu, et al.
Cancer Letters (2019) Vol. 473, pp. 1-12
Closed Access | Times Cited: 45
Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver
KyeongJin Kim, Jin Ku Kang, Young Hoon Jung, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 34
KyeongJin Kim, Jin Ku Kang, Young Hoon Jung, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Clinical, neuroimaging and molecular characteristics ofPPP2R5D-related neurodevelopmental disorders: an expanded series with functional characterisation and genotype–phenotype analysis
Nora Oyama, Pieter Vaneynde, Sara Reynhout, et al.
Journal of Medical Genetics (2022) Vol. 60, Iss. 5, pp. 511-522
Closed Access | Times Cited: 21
Nora Oyama, Pieter Vaneynde, Sara Reynhout, et al.
Journal of Medical Genetics (2022) Vol. 60, Iss. 5, pp. 511-522
Closed Access | Times Cited: 21
PP2A Inhibits Cervical Cancer Cell Migration by Dephosphorylation of p-JNK, p-p38 and the p-ERK/MAPK Signaling Pathway
Hongyun Zheng, Fujin Shen, Yongqing Tong, et al.
Current Medical Science (2018) Vol. 38, Iss. 1, pp. 115-123
Closed Access | Times Cited: 38
Hongyun Zheng, Fujin Shen, Yongqing Tong, et al.
Current Medical Science (2018) Vol. 38, Iss. 1, pp. 115-123
Closed Access | Times Cited: 38
DUSP8 phosphatase: structure, functions, expression regulation and the role in human diseases
Tao Ding, Ya Zhou, Runying Long, et al.
Cell & Bioscience (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Tao Ding, Ya Zhou, Runying Long, et al.
Cell & Bioscience (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 35
The impact of phosphatases on proliferative and survival signaling in cancer
Goutham Narla, Jaya Sangodkar, Christopher B. Ryder
Cellular and Molecular Life Sciences (2018) Vol. 75, Iss. 15, pp. 2695-2718
Open Access | Times Cited: 33
Goutham Narla, Jaya Sangodkar, Christopher B. Ryder
Cellular and Molecular Life Sciences (2018) Vol. 75, Iss. 15, pp. 2695-2718
Open Access | Times Cited: 33
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia
Swagata Goswami, Rajeswaran Mani, Jessica Nunes, et al.
Blood (2021) Vol. 139, Iss. 9, pp. 1340-1358
Open Access | Times Cited: 27
Swagata Goswami, Rajeswaran Mani, Jessica Nunes, et al.
Blood (2021) Vol. 139, Iss. 9, pp. 1340-1358
Open Access | Times Cited: 27
PP2A and Its Inhibitors in Helper T-Cell Differentiation and Autoimmunity
Mohd Moin Khan, Ubaid Ullah Kalim, Meraj Hasan Khan, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 19
Mohd Moin Khan, Ubaid Ullah Kalim, Meraj Hasan Khan, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 19
Dual-specific phosphatase DUSP21 is a novel negative feedback regulator for STAT3
Shigenori SHIKATA, Kazuna Kikkawa, Masahiro Fujimuro, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 752, pp. 151488-151488
Closed Access
Shigenori SHIKATA, Kazuna Kikkawa, Masahiro Fujimuro, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 752, pp. 151488-151488
Closed Access
A functional map of phosphoprotein phosphatase regulation identifies an evolutionary conserved reductase for the catalytic metal ions
Bob Meeusen, Sara M. Ambjørn, Jiri Veis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Bob Meeusen, Sara M. Ambjørn, Jiri Veis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Pathogenic de novo variants in PPP2R5C cause a neurodevelopmental disorder within the Houge-Janssens syndrome spectrum
Iris Verbinnen, Sofia Douzgou, Tzung‐Chien Hsieh, et al.
The American Journal of Human Genetics (2025)
Closed Access
Iris Verbinnen, Sofia Douzgou, Tzung‐Chien Hsieh, et al.
The American Journal of Human Genetics (2025)
Closed Access
Mechanism and application prospect of magnesium-based materials in cancer treatment
Yutong Ma, Yi Wang, Siwei Song, et al.
Journal of Magnesium and Alloys (2025)
Open Access
Yutong Ma, Yi Wang, Siwei Song, et al.
Journal of Magnesium and Alloys (2025)
Open Access
Taishan Pinus Massoniana pollen polysaccharide inhibits the replication of acute tumorigenic ALV-J and its associated tumor growth
Qiuju Wang, Yongqiang Miao, Yulin Xu, et al.
Veterinary Microbiology (2019) Vol. 236, pp. 108376-108376
Closed Access | Times Cited: 27
Qiuju Wang, Yongqiang Miao, Yulin Xu, et al.
Veterinary Microbiology (2019) Vol. 236, pp. 108376-108376
Closed Access | Times Cited: 27
Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review)
Yili Chen, Ching‐Chuan Hsieh, Pei‐Ming Chu, et al.
Oncology Reports (2023) Vol. 49, Iss. 3
Open Access | Times Cited: 9
Yili Chen, Ching‐Chuan Hsieh, Pei‐Ming Chu, et al.
Oncology Reports (2023) Vol. 49, Iss. 3
Open Access | Times Cited: 9
The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets
Elena Kumm, Oliver Pagel, Stepan Gambaryan, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 472-472
Open Access | Times Cited: 22
Elena Kumm, Oliver Pagel, Stepan Gambaryan, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 472-472
Open Access | Times Cited: 22